State of Illinois
90th General Assembly
Legislation

   [ Search ]   [ Legislation ]   [ Bill Summary ]
[ Home ]   [ Back ]   [ Bottom ]


[ Introduced ][ Engrossed ][ House Amendment 001 ]
[ House Amendment 004 ][ Senate Amendment 001 ][ Senate Amendment 002 ]

90_SB1028enr

      720 ILCS 570/102          from Ch. 56 1/2, par. 1102
      720 ILCS 570/206          from Ch. 56 1/2, par. 1206
          Amends the Illinois Controlled Substances Act.   Provides
      that ephedrine is a schedule II controlled substance that may
      only be distributed through prescription.
                                                     LRB9003507RCks
SB1028 Enrolled                                LRB9003507RCks
 1        AN ACT in relation to criminal law.
 2        Be  it  enacted  by  the People of the State of Illinois,
 3    represented in the General Assembly:
 4        Section  5.  The  Anti-Crime  Advisory  Council  Act   is
 5    amended by changing Sections 5 and 7 as follows:
 6        (20 ILCS 3910/5) (from Ch. 38, par. 1305)
 7        Sec.  5.   Duties.   The Council shall have the following
 8    powers and duties:
 9        (a)  to advise  and  assist  in  the  creation  of  local
10    anti-crime  programs,  such  as  Crime  Stoppers,  We-Tip and
11    similar programs designed to solve crimes;
12        (b)  to foster  the  detection  of  crime  and  encourage
13    persons  through  the  program  and otherwise to come forward
14    with information about criminal activity;
15        (c)  to  encourage  the  news  media  to  promote   local
16    anti-crime programs and to inform the public of the functions
17    of the Council;
18        (d)  to  assist  local  anti-crime programs in channeling
19    information reported to those  programs  concerning  criminal
20    activity to the appropriate law enforcement agencies; and
21        (e)  to assist local anti-crime programs in promoting the
22    private funding of local anti-crime programs; and .
23        (f)  to  assist  drug alert programs such as D.A.R.E. and
24    other drug alert programs or drug task forces composed of  or
25    created by State or local law enforcement agencies.
26    (Source: P.A. 83-829.)
27        (20 ILCS 3910/7) (from Ch. 38, par. 1307)
28        Sec.  7.   Definition.   For  the  purposes  of this Act,
29    "local  anti-crime  program"  means  a  plan  established  in
30    various regions of this State which is designed to  encourage
SB1028 Enrolled            -2-                 LRB9003507RCks
 1    the  public  to report incidences of crime to law enforcement
 2    agencies and to assist such agencies in the  apprehension  of
 3    criminal  offenders.  "Local anti-crime program" also means a
 4    drug alert program or drug task force composed of or  created
 5    by local law enforcement agencies.
 6    (Source: P.A. 83-829.)
 7        Section  10.   The  Illinois Controlled Substances Act is
 8    amended by changing Sections 210 and 401.5 and adding Section
 9    216 as follows:
10        (720 ILCS 570/210) (from Ch. 56 1/2, par. 1210)
11        Sec. 210.   (a) The controlled substances listed in  this
12    Section are included in Schedule IV.
13        (b)  Unless  specifically  excepted  or  unless listed in
14    another  schedule,  any  material,  compound,   mixture,   or
15    preparation  containing  limited  quantities  of  any  of the
16    following narcotic drugs, or their salts  calculated  as  the
17    free anhydrous base or alkaloid, as set forth below:
18             (1)  Not  more  than  1  milligram of difenoxin (DEA
19        Drug Code No. 9618) and not less than  25  micrograms  of
20        atropine sulfate per dosage unit.
21             (2) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1,
22        2-diphenyl-3-methyl-2-propionoxybutane).
23        (c)  Unless  specifically  excepted  or  unless listed in
24    another  schedule,  any  material,  compound,   mixture,   or
25    preparation  which  contains  any  quantity  of the following
26    substances having a potential for  abuse  associated  with  a
27    depressant effect on the central nervous system:
28             (1)  Alprazolam;
29             (2)  Barbital;
30             (2.1)  Bromazepam;
31             (2.2)  Camazepam;
32             (3)  Chloral Betaine;
SB1028 Enrolled            -3-                 LRB9003507RCks
 1             (4)  Chloral Hydrate;
 2             (5)  Chlordiazepoxide;
 3             (5.1)  Clobazam;
 4             (6)  Clonazepam;
 5             (7)  Clorazepate;
 6             (7.1)  Clotiazepam;
 7             (7.2)  Cloxazolam;
 8             (7.3)  Delorazepam;
 9             (8)  Diazepam;
10             (8.1)  Estazolam;
11             (9)  Ethchlorvynol;
12             (10)  Ethinamate;
13             (10.1)  Ethyl loflazepate;
14             (10.2)  Fludiazepam;
15             (10.3)  Flunitrazepam;
16             (11)  Flurazepam;
17             (12)  Halazepam;
18             (12.1)  Haloxazolam;
19             (12.2)  Ketazolam;
20             (12.3)  Loprazolam;
21             (13)  Lorazepam;
22             (13.1)  Lormetazepam;
23             (14)  Mebutamate;
24             (14.1)  Medazepam;
25             (15)  Meprobamate;
26             (16)  Methohexital;
27             (17)  Methylphenobarbital (Mephobarbital);
28             (17.1)  Midazolam;
29             (17.2)  Nimetazepam;
30             (17.3)  Nitrazepam;
31             (17.4)  Nordiazepam;
32             (18)  Oxazepam;
33             (18.1)  Oxazolam;
34             (19)  Paraldehyde;
SB1028 Enrolled            -4-                 LRB9003507RCks
 1             (20)  Petrichloral;
 2             (21)  Phenobarbital;
 3             (21.1)  Pinazepam;
 4             (22)  Prazepam;
 5             (22.1)  Quazepam;
 6             (23)  Temazepam;
 7             (23.1)  Tetrazepam;
 8             (24)  Triazolam;
 9             (25)  Zolpidam.
10        (d)  Any  material,  compound,  mixture,  or  preparation
11    which  contains  any  quantity  of  the following substances,
12    including its salts, isomers (whether optical,  position,  or
13    geometric), and salts of such isomers, whenever the existence
14    of such salts, isomers and salts of isomers is possible:
15             (1)  Fenfluramine.
16        (e)  Unless  specifically  excepted  or  unless listed in
17    another  schedule  any  material,   compound,   mixture,   or
18    preparation  which  contains  any  quantity  of the following
19    substances having a stimulant effect on the  central  nervous
20    system,   including  its  salts,  isomers  (whether  optical,
21    position or geometric), and salts of  such  isomers  whenever
22    the existence of such salts, isomers, and salts of isomers is
23    possible within the specific chemical designation:
24             (1)  Cathine ((+)-norpseudoephedrine);
25             (1.1)   Diethylpropion;
26             (1.2)  Fencamfamin;
27             (1.3)  Fenproporex;
28             (2)  Mazindol;
29             (2.1)  Mefenorex;
30             (3)  Phentermine;
31             (4)  Pemoline  (including  organometallic  complexes
32        and chelates thereof);
33             (5) Pipradrol;
34             (6) SPA ((-)-1-dimethylamino-1, 2-diphenylethane).
SB1028 Enrolled            -5-                 LRB9003507RCks
 1        (f)  The  Department  may  except  by  rule any compound,
 2    mixture, or preparation containing any  depressant  substance
 3    listed  in  subsection (b) from the application of all or any
 4    part of this Act if the  compound,  mixture,  or  preparation
 5    contains  one or more active medicinal ingredients not having
 6    a depressant effect on the central nervous system, and if the
 7    admixtures are included therein  in  combinations,  quantity,
 8    proportion,  or  concentration that vitiate the potential for
 9    abuse of the substances which have a depressant effect on the
10    central nervous system.
11        (g)  Except as otherwise provided  in  Section  216,  any
12    material, compound, mixture, or preparation that contains any
13    quantity of the following substance having a stimulant effect
14    on   the   central   nervous  system,  including  its  salts,
15    enantiomers  (optical  isomers)  and  salts  of   enantiomers
16    (optical isomers):
17             (1)  Ephedrine, its salts, optical isomers and salts
18        of   optical   isomers   as  the  only  active  medicinal
19        ingredient  or  in   combination   with   therapeutically
20        insignificant  quantities  of  another  active  medicinal
21        ingredient.
22    (Source: P.A. 89-202, eff. 10-1-95.)
23        (720 ILCS 570/216 new)
24        Sec. 216.  Ephedrine.
25        (a)  The  following  drug  products containing ephedrine,
26    its salts, optical isomers and salts of optical isomers shall
27    be exempt from the application of Sections  312  and  313  of
28    this  Act  if they: (i) may lawfully be sold over-the-counter
29    without a prescription under  the  Federal  Food,  Drug,  and
30    Cosmetic  Act;  (ii)  are  labeled  and  marketed in a manner
31    consistent with Section 341.76 of Title 21  of  the  Code  of
32    Federal  Regulations;  (iii) are manufactured and distributed
33    for legitimate medicinal use in  a  manner  that  reduces  or
SB1028 Enrolled            -6-                 LRB9003507RCks
 1    eliminates   the  likelihood  of  abuse;  and  (iv)  are  not
 2    marketed, advertised,  or  labeled  for  the  indications  of
 3    stimulation,    mental   alertness,   weight   loss,   muscle
 4    enhancement, appetite control, or energy:
 5             (1)  Solid oral dosage forms, including soft gelatin
 6        caplets, which are formulated pursuant to 21 CFR  341  or
 7        its  successor, and packaged in blister packs of not more
 8        than 2 tablets per blister.
 9             (2)  Anorectal preparations containing not more than
10        5% ephedrine.
11        (b)  The  marketing,  advertising,  or  labeling  of  any
12    product containing ephedrine, a salt of ephedrine, an optical
13    isomer of ephedrine, or  a  salt  of  an  optical  isomer  of
14    ephedrine,   for   the  indications  of  stimulation,  mental
15    alertness, weight  loss,  appetite  control,  or  energy,  is
16    prohibited.   In determining compliance with this requirement
17    the Department may consider the following factors:
18             (1)  The packaging of the drug product;
19             (2)  The name and labeling of the product;
20             (3)  The manner of  distribution,  advertising,  and
21        promotion of the product;
22             (4)  Verbal   representations  made  concerning  the
23        product;
24             (5)  The duration, scope, and significance of  abuse
25        or misuse of the particular product.
26        (c)  A   violation   of   this   Section  is  a  Class  A
27    misdemeanor.   A  second  or  subsequent  violation  of  this
28    Section is a Class 4 felony.
29        (d)  This Section does not apply to dietary  supplements,
30    herbs,  or  other natural products, including concentrates or
31    extracts, which:
32             (1)  are not otherwise prohibited by law; and
33             (2)  may  contain  naturally  occurring   ephedrine,
34        ephedrine  alkaloids, or pseudoephedrine, or their salts,
SB1028 Enrolled            -7-                 LRB9003507RCks
 1        isomers, or salts of isomers, or a combination  of  these
 2        substances, that:
 3                  (i)  are  contained  in  a  matrix  of  organic
 4             material; and
 5                  (ii)  do  not exceed 15% of the total weight of
 6             the natural product.
 7        (720 ILCS 570/401.5)
 8        Sec. 401.5.  Chemical  breakdown  of  illicit  controlled
 9    substance.
10        (a)  It  is  unlawful  for  any  person  to manufacture a
11    controlled substance prohibited by  this  Act  by  chemically
12    deriving  the  controlled  substance  from  one or more other
13    controlled substances prohibited by this Act.
14        (a-5)   It is unlawful for  any  person  to  possess  any
15    substance  with the intent to use the substance to facilitate
16    the manufacture of any controlled or counterfeit substance or
17    controlled substance analog other than as authorized by  this
18    Act.
19        (b)  A violation of this Section is a Class 4 felony.
20    (Source: P.A. 88-283.)

[ Top ]